News Story: Full Text
Sponsored By
Cedars-Sinai Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website


Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like Cancer Cells in Glioblastoma.

Posted on: 08/17/2007

Stem Cells. 2007 Jul 12; [Epub ahead of print] Related Articles

Cyclopamine-Mediated Hedgehog Pathway Inhibition Depletes Stem-Like Cancer Cells in Glioblastoma.

Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W, Vescovi AL, Dimeco F, Olivi A, Eberhart CG.

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Brain tumors can arise following deregulation of signaling pathways normally activated during brain development, and may derive from neural stem cells\. Given the requirement for Hedgehog in non-neoplastic stem cells, we investigated if Hedgehog blockade could target the stem-like population in glioblastoma (GBM)\. We found that Gli1, a key Hedgehog pathway target, was highly expressed in 5 of 19 primary GBMs and in 4 of 7 GBM cell lines\. Shh ligand was expressed in some primary tumors, and in GBM-derived neurospheres, suggesting a potential mechanism for pathway activation\. Hedgehog pathway blockade by cyclopamine caused a 40-60% reduction in growth of adherent glioma lines highly expressing Gli1, but not in those lacking evidence of pathway activity\. When GBM-derived neurospheres were treated with cyclopamine, then dissociated and seeded in media lacking the inhibitor, no new neurospheres formed, suggesting the clonogenic cancer stem cells had been depleted\. Consistent with this hypothesis, the stem-like fraction in gliomas marked by both aldehyde dehydrogenase activity and Hoechst dye excretion (side population) was significantly reduced or eliminated by cyclopamine\. In contrast, we found that radiation treatment of our GBM neurospheres increased the percentage of these stem-like cells, suggesting that this standard therapy preferentially targets better-differentiated neoplastic cells\. Most importantly, viable GBM cells injected intracranially following Hedgehog blockade were no longer able to form tumors in athymic mice, indicating a cancer stem cell population critical for ongoing growth had been removed.

PMID: 17628016 [PubMed - as supplied by publisher]

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557